ArticleAntioxidants (Basel, Switzerland)2022

Novel Series of Dual NRF2 Inducers and Selective MAO-B Inhibitors for the Treatment of Parkinson's Disease.

Pablo Duarte et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.